What Sylvan does

Sylvan is a fungal biotechnology company founded in 1932 by Dr. James Sinden that has grown into the world's leading producer of mushroom spawn, operating across 65 countries with eight regional offices and dedicated strain maintenance laboratories in Kittanning, USA and Langeais, France. The company maintains a proprietary genetic library of 600+ mushroom strains across 50+ species and sells into four application verticals: Food (Agaricus, Oyster, Shiitake, Tempeh/Koji starter cultures, and sporeless varieties including SPX 281 and Bavarian Brown), Health (red yeast rice, Duddingtonia flagrans animal health, Blazei H1X1), Agriculture (NemaPro nematode biocontrol, Trichoderma, Beauveria bassiana, Bacillus amyloliquefaciens TGAI), and Materials (GRX Ganoderma strains and sterile substrates for the myco-materials industry). Core technology centers on solid-state fermentation for spawn production, proprietary genetic markers, and whole genome sequencing applied to molecular marker-assisted breeding, with patented strains protected across jurisdictions.

Sylvan operates a sales-led, enterprise B2B go-to-market model, selling quote-based through regional offices with embedded CropCare technical advisory teams that perform on-farm visits and host global workshops and demonstration trials at the Sylvan Research International Demonstration Centre in Horst, Netherlands. Revenue is generated across one-time spawn sales, fungal biotechnology product sales, technical advisory services, and direct-to-consumer health products through sylvanwellness.com. The company is majority-owned by KKR, with Novo Holdings as a significant minority investor following two undisclosed rounds in April 2025 and January 2026 that included TPG NewQuest, Ping'An Capital, China Post Insurance, Schroders Capital, and Tsao Pao Chee. Recent strategic activity centers on the EuroMycel acquisition from Bonduelle (October 2024), expansion of the Huai'an, China headquarters with a new APAC R&D Center (opened March 2026), and execution of Strategy 2028 targeting expansion across all four verticals. Jackie Qi serves as CEO and Chen Lichtenstein as Chairman.

Name

Sylvan

Legal name

Sylvan

Website

https://sylvan.bio

Company type

Private

Founded year

1932

Operating status

Operating

Headcount range

251–500 employees

Short description

Sylvan is a fungal biotechnology company producing mushroom spawn and fungal-based products for commercial growers and the agriculture, health, and materials industries. Operating across 65 countries with proprietary patented strains and dedicated R&D infrastructure, the majority KKR-owned company serves enterprise B2B customers globally.

Ownership category

akta.pro rank

Product category

Fungal Biotechnology and Mushroom Spawn

NAICS

Mushroom Production (111411), Greenhouse, Nursery, and Floriculture Production (1114), Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing (3253)

SIC

Agricultural Production-Crops (100), Agricultural Services (700), Wholesale-Farm Product Raw Materials (5150), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Mushroom & Fungi Production (Indoor/Protected) (AFAGAHAK)

akta.pro secondary industries

Mushroom Farming (Button, Oyster, Shiitake) (AFAGADAJ), Pest Control Product Supply (Fumigants, Traps, Lures, Applicator Equipment) (AFAOAIAN), Mycoprotein & Fungal Proteins (Fusarium/Mycelium-Based) (AFAJAHAE)

Keywords

• Mushroom spawn production
• Fungal biotechnology products
• Biological crop protection
• Mushroom strain breeding
• Agricultural biocontrol agents

Headquarters

HQ city

Kittanning

HQ country

United States

HQ region

North America

Offices8 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Mushroom Spawn Sales: Global leading producer of mushroom spawn serving customers across 65 countries. Revenue from high-performance spawn strains including Agaricus, Oyster, Shiitake varieties sold to commercial mushroom growers.
2. Fungal Biotechnology Solutions: Provides fungal-based products for food, health, agriculture, and materials sectors. Includes TGAI (technical grade active ingredients), biological control products, biostimulants, and nutritional supplements.
3. Health Products: Red yeast rice products sold in bulk or capsules through sylvanwellness.com; Duddingtonia and Blazei H1X1 animal health products through feed supplement partnerships.
4. Technical Advisory Services: CropCare advisory services including on-farm visits, comprehensive crop performance analyses, and global workshops for mushroom growers covering composting, growing optimization, and pest management.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Sylvan manufactures and distributes high-performance mushroom spawn (Agaricus, Oyster, Shiitake, sporeless varieties) and fungal-based biological products for commercial growers, agriculture, health, and materials markets across 65 countries. Its portfolio also includes fungal biocontrol agents (e.g., NemaPro nematodes, Trichoderma, Beauveria bassiana), health supplements (Red Yeast Rice, Duddingtonia Flagrans, Blazei H1X1), Tempeh starter cultures, GRX Ganoderma strains, and sterile substrates for myco-material cultivation. Sales are conducted direct via eight regional offices supported by global CropCare technical advisory teams.

Product overview

Sylvan is a fungal biotechnology company offering a diversified portfolio of mushroom spawn and fungal-based products across four market segments: Food, Health, Agriculture, and Materials. The Food division provides over 600 mushroom strains including Agaricus, Oyster, Shiitake, and sporeless varieties (SPX 281, Bavarian Brown), plus Tempeh starter cultures. The Health division offers Red Yeast Rice, Duddingtonia Flagrans, and Blazei H1X1 for human and animal health applications. The Agriculture division supplies NemaPro nematodes, Bacillus amyloliquefaciens, and fungal biocontrol products (TGAI) including Trichoderma and Beauveria bassiana strains. The Materials division provides GRX Ganoderma strains and sterile substrates for myco-material industries. Supporting products include Nexus, Mylo, MyloPro, Sprint M, and ASR. The company operates globally with acquired brand EuroMycel.

Differentiator

Problem solved

Functional benefit

Brands

• NemaPro: Biological application containing live Steinernema feltiae nematodes to control sciarid fly larvae for agriculture.
• SPX 281
• Bavarian Brown
• Nexus
• Mylo
• MyloPro
• Sprint M
• ASR

Products and services

• Agaricus Mushroom Strains

Named customers10 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Ten partnerships are on record, tiered major and minor.

• EuroMycel (from Bonduelle)majorStrategic or Co-development Partner · 14 October 2024Sylvan Europe acquired EuroMycel from Bonduelle, strengthening position in European edible fungi market. 40 employees, known for high-quality agaricus strains and grain-based spawn production expertise.
• BonduelleminorOthers · 14 October 2024Previous owner of EuroMycel; transaction expected to close end of 2024 pending legal approvals.
• Frederic Mathieu (EuroMycel)minorOthers · 14 October 2024EuroMycel Managing Director continuing under Sylvan leadership with existing team.
• European Universities and Research InstitutesmajorStrategic or Co-development PartnerSylvan accesses resources from Asian universities and institutions through new APAC R&D Center. Global collaborations with leading universities and institutes drive continuous innovation.
• Asia Pacific Academic InstitutionsmajorStrategic or Co-development PartnerNew APAC R&D Center in Huai'an provides access to Asian university and institutional resources for accelerated innovation development.
• Gurelan MyceliummajorStrategic or Co-development PartnerSpanish subsidiary Sylvan Iberia partnered with Gurelan Mycelium to complete solar energy project reducing environmental footprint. Combined operations at Dutch Mushroom Days 2026 exhibition.
• O2MminorImplementation/ SI/ Consulting PartnerExpertise partner supporting C-metric carbon footprint measurement project at Sylvan Europe facilities.
• Wageningen UniversityminorStrategic or Co-development PartnerAcademic partner that developed PLX sporeless mushroom variety licensed/commercialized through Sylvan.
• FiBL (Research Institute of Organic Agriculture)minorOthersNemaPro product complies with FiBL organic standards.
• OMRI (Organic Materials Review Institute)minorOthersNemaPro product compliant with OMRI organic standards for natural pest control.

Scale indicators7 records

Recent moves10 records

Expansion highlights7 records

Direct peers

• Amycel: One of the world's largest producers of mushroom spawn and a direct competitor to Sylvan across Agaricus and specialty mushroom varieties. Both companies compete on strain performance, technical advisory, and global grower relationships.
• Lambert Spawn: Long-established North American mushroom spawn producer. Comparable to Sylvan in serving large commercial Agaricus growers with proprietary strains and on-farm CropCare-style technical support.
• Italspawn: Italian mushroom spawn producer operating across Europe. Directly competes with Sylvan's Somycel and EuroMycel operations in spawn supply for European Agaricus and Pleurotus growers.
• Mycelia: Belgian spawn and mycelium technology supplier serving European mushroom growers. Comparable to Sylvan in offering proprietary strains and substrate expertise for commercial cultivation.

Broad incumbents

• Novonesis: Global biosolutions leader with a broad portfolio of microbial and fungal ingredients for food, agriculture, and health. Overlaps with Sylvan's Health, Agriculture, and Materials ambitions at much greater scale.
• Koppert: Global biological crop protection and pollination specialist. Comparable to Sylvan's biocontrol/biostimulants division (NemaPro, Bacillus, Trichoderma products) with established agricultural distribution.
• Lallemand: Privately held global developer of yeasts, bacteria, and fungal-based products for baking, brewing, food, and agriculture. Overlaps with Sylvan across fungal biotechnology, agricultural biologicals, and health-adjacent markets.

Emerging players

• Ecovative Design: Leading myco-materials company using mycelium for packaging, textiles, and food. Competes with Sylvan's Materials division in supplying strains and substrates to the mycelium products industry.
• Indigo Ag: Agricultural technology and biologicals company working on microbial seed treatments and crop inputs. Listed as a Sylvan partner on the quality page; comparable as a peer in the agricultural biologicals space.

Others

• Bonduelle: Global vegetable and processed-food group that previously owned EuroMycel, which Sylvan acquired in 2024. Compares as a vertical counterpart: large-scale buyer of mushroom and vegetable raw materials from growers supplied by Sylvan's spawn.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/sylvaninc
• LinkedInlinkedin.com/company/sylvaninc
• Instagraminstagram.com/sylvan_inc

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries10 records

Funding overview

Funding rounds2 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sylvan